Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05245695 · ClinicalTrials.gov registry record
Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)
A clinical trial of Endometriosis, sponsored by Aspira Women's Health.
- Recruiting
- Registry status
- 1,200
- Enrollment target
- 10
- Study locations
NCT05245695: Recruiting study of Endometriosis, sponsored by Aspira Women's Health.
NCT05245695 is a study of Endometriosis that is actively recruiting participants, run by Aspira Women's Health. The registered enrollment target is 1,200 participants, above the 239-participant average among 48 other Endometriosis trials with a reported enrollment target (402% higher). The trial reports 10 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05245695, a study of Endometriosis, is actively recruiting participants, sponsored by Aspira Women's Health.
- RECRUITING
- Registry status
- 1,200 participants
- Enrollment target
- 10
- Study locations
Study Summary
The goal of this observational study is to determine the clinical validity of a deep neural network algorithm that utilizes protein biomarker detection of Endometriosis - "EndoCheck" - as an "aid in diagnosis" for endometriosis and to show validity as a diagnostic test
Primary Outcome
The primary endpoint of the study is to optimize the test to achieve the success criteria of at least 94% and 79% sensitivity and specificity, respectively
Conditions Studied
Interventions
- OTHER Observational study, no intervention
Study Locations (10)
Arizona
- New Horizons Clinical Trials - Chandler
California
- Velvet Clinical Research - Burbank
Delaware
- Reproductive Associates of Delaware (RAD) - Newark
Georgia
- Midtown OBGYN North - Columbus
Indiana
- Cindy Basinski, MD - Forest Hill
Maryland
- Johns Hopkins School of Medicine - Baltimore
New York
- Nezhat Surgery for Gynecology/Oncology - Valley Stream
Ohio
- Seven Hills Clinical Research - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2022-07-12 |
| Est. Completion | 2026-06-30 |
What NCT05245695 shows while recruiting
NCT05245695 is an observational study that tracks outcomes without assigning an intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, above the 239-participant average among 48 other Endometriosis trials with a reported enrollment target (402% higher).
The record links to 1 condition, with Endometriosis appearing as the primary indexed condition, and to 1 intervention - of which Observational study, no intervention is the first listed.
NCT05245695 lists 10 locations in 10 states (Arizona, California, Delaware).
Frequently Asked Questions
What is clinical trial NCT05245695 about?
NCT05245695 is a clinical study titled "Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)". The goal of this observational study is to determine the clinical validity of a deep neural network algorithm that utilizes protein biomarker detection of Endometriosis - "EndoCheck" - as an "aid in diagnosis" for endometriosis and to show validity as a diagnostic test
What is the current status of trial NCT05245695?
This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 2022-07-12. Estimated completion is 2026-06-30.
What conditions does trial NCT05245695 study?
This clinical trial studies the following conditions: Endometriosis.
What interventions are being tested in trial NCT05245695?
The interventions under investigation include: Observational study, no intervention (OTHER).
Who is sponsoring clinical trial NCT05245695?
This trial is sponsored by Aspira Women's Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05245695 being conducted?
This trial has 10 study locations across Arizona, California, Delaware, Georgia, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometriosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05245695's enrollment target sits among peer trials
1,200 3rd of 48 higher than 46 of 48 other Endometriosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometriosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Thromboxane Function in Women With Endometriosis
RECRUITING · Phase 4
-
Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
RECRUITING · NA
-
The Impact of Yoga on Endometriosis-Related Pain
RECRUITING · NA
-
Endometriosis and Microvascular Dysfunction: Role of Inflammation
RECRUITING · Early Phase 1
-
Physical Therapy After Endometriosis Excision
RECRUITING · NA
-
Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI